Company Monitoring Page for Roche

latest headlines for company on cafepharma

Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
Tags:
biosimilars, AbbVie, Roche, Amgen, Rituxan, Herceptin, Avastin, Neupogen, Neulasta, Epogen, Humira, Perjeta, Gazyva
Roche brings an Alzheimer's drug back from the brink with another PhIII endeavor
Fierce Biotech
Wed, 07/22/15 - 08:33 am
Tags:
Roche, Alzheimer's disease, gantenerumab
Top 10 pharma companies in social media
Fierce Pharma Marketing
Mon, 07/20/15 - 09:12 am
Tags:
social media, Boehringer Ingelheim, Bayer, Novartis, JNJ, Merck, Abbott Labs, GSK, Roche, Novo Nordisk, AstraZeneca
Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezo
Fierce Biotech
Mon, 07/13/15 - 09:49 am
Tags:
Roche, FDA, PD-L1, atezolizumab
Roche's MS hopeful will amp up payer pricing pressure, analyst says
Fierce Pharma Marketing
Wed, 07/8/15 - 11:41 am
Tags:
Roche, MS, multiple sclerosis, ocrelizumab
Another Roche Alzheimer's drug disappoints
BioPharma Dive
Mon, 07/6/15 - 12:09 pm
Tags:
Roche, Alzheimer's disease, Evotec, sembragiline
Roche forced to concede another flop for Alzheimer's program
Fierce Biotech
Wed, 07/1/15 - 12:01 pm
Tags:
Roche, Alzheimer's disease, sembragiline, Evotec
Roche heralds PhIII successes for MS, but some tough rivals lie in wait
Fierce Biotech
Tue, 06/30/15 - 10:43 am
Tags:
Roche, multiple sclerosis, ocrelizumab, MS
Pharma ad budgets to dip in 2016, but J&J, Pfizer, Roche and Novartis should still top $2B
Fierce Pharma Marketing
Mon, 06/22/15 - 12:52 pm
Tags:
Pfizer, Roche, JNJ, Novartis, drug ads
Deal buzz: Forget Pfizer. Traders bet GSK as a match for J&J, Roche
Fierce Pharma
Tue, 06/16/15 - 12:02 pm
Tags:
Pfizer, GSK, M&A, JNJ, Roche
Roche slashes hep C drug price 65% for government clinics in India
Fierce Pharma Asia
Mon, 06/15/15 - 09:00 pm
Tags:
India, Roche, hepatitis C, drug pricing
Canadians hope $250 mln trial can revive failed Roche heart drug
Yahoo/Reuters
Tue, 06/9/15 - 11:59 am
Tags:
Canada, Roche, drug trials, DalCor Pharmaceuticals, dalcetrapib
Roche Takes Another Shot at Alzheimer’s After Biogen Success
Bloomberg
Tue, 06/9/15 - 10:20 am
Tags:
Roche, Biogen, Alzheimer's disease, gantenerumab
Roche Builds a Wide Moat With Dominant Oncology and Diagnostics Franchises
Morningstar
Mon, 06/8/15 - 10:07 pm
Tags:
Roche, oncology, diagnostics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
Tags:
ASCO, Ignyta, Immunogen, Puma Biotechnology, AbbVie, Roche, Bristol-Myers Squibb, Seattle Genetics, Juno Therapeutics
Roche unchallenged at top of cancer sellers, but Celgene could fight Novartis for No. 2
Fierce Pharma
Wed, 06/3/15 - 12:26 pm
Tags:
Roche, Celgene, oncology, Novartis
Roche, Novartis and Bayer snag NICE OKs
Fierce Pharma
Tue, 06/2/15 - 04:50 pm
Tags:
NICE, Roche, Novartis, Bayer, Gazyvaro, Cosentyx, Eylea
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
Tags:
biotech, ASCO, Bristol-Myers Squibb, Immunogen, Oncothyreon, Clovis Oncology, CTI BioPharma, Exelixis, Roche, Amgen, AstraZeneca, Puma Biotechnology, Vascular Biogenics, Immunomedics, Momenta, Eli Lilly, Juno Therapeutics, Express Scripts
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Tue, 06/2/15 - 09:15 am
Tags:
Amgen, Roche, triple negative breast cancer, Talimogene Laherparepvec, atezolizumab, colorectal cancer
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
Tags:
ASCO, Oncothyreon, Immunogen, Bristol-Myers Squibb, Merck, Clovis Oncology, Roche, CTI BioPharma, Celldex Therapeutics, Puma Biotechnology, Express Scripts

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.